Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDPharmaCyte Biotech Inc Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 1 | -$0.06 | -$0.06 | -$0.06 |
| Q2 2026 | 1 | -$0.06 | -$0.06 | -$0.06 |
| Q3 2026 | 1 | -$0.06 | -$0.06 | -$0.06 |
| Q4 2026 | 1 | -$0.05 | -$0.05 | -$0.05 |
| Q1 2027 | 1 | -$0.04 | -$0.04 | -$0.04 |
| Q2 2027 | 1 | -$0.07 | -$0.07 | -$0.07 |
| Q3 2027 | 1 | -$0.08 | -$0.08 | -$0.08 |
| Q4 2027 | 1 | -$0.08 | -$0.08 | -$0.08 |
| Q1 2028 | 1 | -$0.09 | -$0.09 | -$0.09 |
PharmaCyte Biotech Inc Earnings Date And Information
PharmaCyte Biotech Inc last posted its earnings results on Tuesday, March 17th, 2026. The company reported $0.13 earnings per share for the quarter, topping analysts' consensus estimates of $-0.06 by $0.19. The company had revenue of 0 for the quarter and had revenue of 0 for the year. PharmaCyte Biotech Inc has generated $3 earnings per share over the last year ($3.19 diluted earnings per share) and currently has a price-to-earnings ratio of -0.74. PharmaCyte Biotech Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
PharmaCyte Biotech Inc Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 03/17/2026 | Q3 2026 | -$0.06 | -$0.17 | -0.11 | $0 | $0 |
| 12/18/2025 | Q2 2026 | N/A | -$1.24 | N/A | $0 | $0 |
| 09/15/2025 | Q1 2026 | N/A | -$1.23 | N/A | $0 | $0 |
| 08/08/2025 | Q4 2025 | N/A | $1.60 | N/A | N/A | $0 |
| 03/17/2025 | Q3 2025 | N/A | -$0.44 | N/A | N/A | $0 |
| 12/13/2024 | Q2 2025 | N/A | -$0.39 | N/A | N/A | $0 |
| 09/16/2024 | Q1 2025 | N/A | $1.90 | N/A | N/A | $0 |
| 08/13/2024 | Q4 2024 | N/A | -$0.32 | N/A | N/A | $0 |
| 03/18/2024 | Q3 2024 | N/A | -$0.65 | N/A | N/A | $0 |
| 12/15/2023 | Q2 2024 | N/A | -$0.26 | N/A | N/A | $0 |
| 09/18/2023 | Q1 2024 | N/A | -$0.54 | N/A | N/A | $0 |
| 07/31/2023 | Q4 2023 | -$0.09 | -$0.01 | 0.08 | N/A | $0 |
| 03/16/2023 | Q3 2023 | -$0.08 | $0.00 | 0.08 | N/A | $0 |
| 12/14/2022 | Q2 2023 | -$0.08 | -$0.09 | -0.01 | N/A | $0 |
| 09/14/2022 | Q1 2023 | -$0.07 | -$0.07 | -0 | N/A | $0 |
| 07/28/2022 | Q4 2022 | -$0.03 | -$0.08 | -0.05 | N/A | $0 |
| 03/15/2022 | Q3 2022 | -$0.05 | -$0.04 | 0.01 | N/A | $0 |
| 12/14/2021 | Q2 2022 | -$0.07 | -$0.06 | 0.01 | N/A | $0 |
| 09/14/2021 | Q1 2022 | N/A | -$0.64 | N/A | N/A | $0 |
| 08/10/2021 | Q4 2021 | N/A | -$0.62 | N/A | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
PharmaCyte Biotech Inc Earnings: FAQ's
In the previous quarter, PharmaCyte Biotech Inc (:PMCB) reported $0.13 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.06 by $0.19.
The conference call for PharmaCyte Biotech Inc's latest earnings report can be listened to online.
The conference call transcript for PharmaCyte Biotech Inc's latest earnings report can be read online.
PharmaCyte Biotech Inc (:PMCB) has a recorded net income of $30.66 M.PharmaCyte Biotech Inc has generated $3.19 earnings per share over the last four quarters.
PharmaCyte Biotech Inc (:PMCB) has a price-to-earnings ratio of -0.74 and price/earnings-to-growth ratio is 0.02.